Application 050697
- Type
- NDA
- Sponsor
- ABBVIE INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BIAXIN XL | CLARITHROMYCIN | TABLET;ORAL | 250MG | No | No |
| 002 | BIAXIN XL | CLARITHROMYCIN | TABLET;ORAL | 500MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clarithromycin | CLARITHROMYCIN | A-S Medication Solutions | 25debd85-0840-4f8d-9898-027772061dd2 | 2025-06-09 | Warnings, Adverse reactions | CLARITHROMYCIN |
| clarithromycin | CLARITHROMYCIN | Actavis Pharma, Inc. | d5be5f12-6392-4d7d-ab23-ebc205ac1a85 | 2025-05-30 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Coupler LLC | 2d6cfd87-9b8c-bba9-e063-6294a90aff5a | 2025-02-05 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | NuCare Pharmaceuticals,Inc. | 9143b79c-4c79-43ac-e053-2995a90ad708 | 2025-02-04 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | DirectRx | d22bd12c-737b-4aab-e053-2995a90aff60 | 2025-01-20 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Bryant Ranch Prepack | 27e02b77-4332-49e0-8d0c-a072cf5dff92 | 2024-05-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Proficient Rx LP | 28f60574-4ecd-441c-aebe-5b1d18033ef6 | 2024-02-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Bryant Ranch Prepack | 0c7d8391-50ef-4827-abe6-e0fc0c2f1636 | 2024-01-16 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Rising Pharma Holdings, Inc. | 0c4db97f-f4c9-4cac-9f12-9db1d967ebeb | 2024-01-05 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | A-S Medication Solutions | adba78c2-9e51-4bed-8c6a-6f977f79c40c | 2023-12-14 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Lannett Company, Inc. | 9bf207c0-86eb-4f3b-92e7-f65f3fccd5a7 | 2023-11-13 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Aurobindo Pharma Limited | 9aaffb41-408c-4372-8fd5-1d649450c0e9 | 2023-10-10 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Lannett Company, Inc. | 71a836d0-d60f-6418-e053-2a95a90aa6ef | 2023-09-22 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Sandoz Inc | 22457862-0f88-4be8-b507-1c8f264269f2 | 2023-09-13 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | A-S Medication Solutions | 1d6f5a9d-51b2-4e0d-b573-ccf08fe6ea23 | 2023-07-31 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Sandoz Inc | b98b02bb-2609-49a0-b29f-e5911aa0cbc1 | 2023-05-30 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Alembic Pharmaceuticals Limited | 268d21f9-02c9-41b0-9487-7968ea12720d | 2023-05-29 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Alembic Pharmaceuticals Inc. | cde51c9f-f7b8-413f-8b8e-e56370cd5754 | 2023-05-26 | Warnings, Adverse reactions | CLARITHROMYCIN |
| CLARITHROMYCIN | CLARITHROMYCIN | Chartwell RX, LLC. | 99d2fd6b-39ca-42f9-ad06-30e7fbc22c47 | 2022-12-23 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Proficient Rx LP | b1bdf526-4f16-4130-b614-4cb678f060d7 | 2021-01-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 8022 | SUPPL | 2004-07-21 |